FinTechFunding

Telix Pharmaceuticals: Acquires Optimal Tracers

Telix Pharmaceuticals Acquires Optimal Tracers

  • Telix Pharmaceuticals (TLX) enters an agreement with Northern California PET Imaging Center to acquire radiochemistry specialist Optimal Tracers
  • The company believes the acquisition will “bolster” its in-house radiochemistry development capability by adding a highly-skilled team and establishing a US-based lab
  • Telix will also own Optimal Tracer’s facility, which has a radiation and pharmaceutical manufacturing licence to support pre-clinical and clinical research
  • Optimal Tracer’s CEO, Ruth Tesar, says she’s looking forward to providing Telix with the radiochemistry knowledge and experience to contribute to its future success
  • TLX shares are trading at $6.78 at 2:49 pm AEDT
Previous article
IOUpay: Launches $1m share purchase plan
Next article
ETH vs BTC: Which Asset Will Perform Better in the Long-Term Perspective?
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

eToro Strengthens Crypto Portfolio with Zengo Acquisition

Deal expands eToro's offerings in the cryptocurrency sector.Highlights: eToro is acquiring crypto wallet Zengo to expand its services.The...
FinTech

Revolut Launches Platform to Streamline Overseas Talent Hiring

Revolut's new service aims to simplify global recruitment for businesses.Highlights: Revolut launches a platform for hiring overseas talent.The...
FinTech

Revolut Strengthens Business Recruitment Platform in New Markets

The fintech giant expands its offerings targeting recruitment needs globally.Highlights: Revolut enhances its platform for business recruitment.The expansion...
FinTech

UniCredit Selects Slate to Strengthen Retail Investment Services

The partnership aims to enhance digital investment options for customers.Highlights: UniCredit partners with Slate for enhanced retail investment...